NLRP3 and liver dysplastic nodule: In turn, inhibition of NLRP3 inflammasome activation ameliorates renal injury and fibrosis in diabetic nephropathy (DN) (216), suggesting that targeting the NLRP3 inflammasome is a promising approach for the treatment of DN (217).